Page 7 - Brianm Strem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brianm strem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brianm Strem Today - Breaking & Trending Today

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces First Patient Enrolled in Phase 2 Study Evaluating KIO-201 for Persistent Corneal Epithelial Defects

Salt Lake City, Utah (Newsfile Corp. - July 5, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced enrolling the first patient as a part of a Phase 2 study ....

United States , Salt Lake City , Francina Agosti , Innov Ophthalmol , Brianm Strem , Utah Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Persistent Corneal Epithelial Defect , Chief Executive Officer , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report , Corneal Epithelial Defects , Med Hypothesis Discov Innov ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Reports 2021 Results and Provides Business Update

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Reports 2021 Results and Provides Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Salt Lake City , United States , Erin Parsons , David Hollander , Francina Agosti , Brianm Strem , Utah Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Chief Executive Officer , Retinitis Pigmentosa , Orphan Drug Designation , Ocular Presentation , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Granted Orphan Drug Designation for KIO-301, an Investigational Drug for the Treatment of Retinitis Pigmentosa (RP)

Salt Lake City, Utah (Newsfile Corp. - March 18, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") has received Orphan Drug Designation from the U.S. Food and Drug Administration ....

Salt Lake City , United States , New South Wales , Francina Agosti , Brianm Strem , Utah Newsfile Corp , Drug Administration , Kiora Pharmaceuticals Inc , Orphan Drug Designation , Retinitis Pigmentosa , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Participation at 2022 BIO CEO & Investor Conference

Salt Lake City, Utah (Newsfile Corp. - February 8, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today that Brian M. Strem, Ph.D, President and CEO of Kiora ....

New York , United States , Salt Lake City , Francina Agosti , Brianm Strem , Utah Newsfile Corp , Marriott Marquis , Company Investor Relations , Kiora Pharmaceuticals Inc , New York City , Investor Relations , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board

Salt Lake City, Utah (Newsfile Corp. - February 1, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today the appointment of Erin Parsons as a new independent ....

Salt Lake City , United States , Erin Parson , Erin Parsons , Francina Agosti , Paul Chaney , Brianm Strem , Utah Newsfile Corp , Parsons Medical Communications , Eyegate Pharmaceuticals Inc , Kiora Pharmaceuticals Inc , Executive Chairman , Stephen From , Eyegate Pharmaceuticals , Lead Independent Director , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,